
Unleashing innovation: Pharma, how can your new product launch solve the NHS’ most critical challenges?
On November 3rd 2017 the UK Government published its endorsement of the Accelerated Access Review (Making a reality of the Accelerated Access Review: Improving patient access to breakthrough technologies and treatments in a cost-effective model). At the core of the Accelerated Access Review is the proposal to get strategically important, cost-effective products into the NHS as … Continued